Hospital Universtiario Virgen del Rocio

Seville 41013

0 studies enrolling now · 3 studies all time

What they study most

HER2-Positive Primary Breast Cancer, Non-alcoholic Steatohepatitis, Residual Invasive Breast Cancer, Von Willebrand Disease, Type 3

Studies at this site

• An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment — Running, not enrolling
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis — Stopped early